Suicidal behavior has neurobiological determinants independent of the psych
iatric illnesses with which it is associated. We have found that some patie
nts with major depression are vulnerable to acting on suicidal impulses. Th
is vulnerability results from the interaction between triggers or precipita
nts and the threshold for suicidal behavior. An important factor in setting
an individual's threshold for acting on suicidal impulses is brain seroton
ergic function. Serotonin function has been shown to be lower in suicide at
tempters by studies measuring serotonin metabolites in cerebrospinal fluid
and studies of prolactin response to fenfluramine. Postmortem studies of su
icide victims also reveal decreased serotonin activity in the ventrolateral
prefrontal cortex. New neuroimaging paradigms, such as positron emission t
omography (PET), offer an opportunity to visualize serotonin function in vi
vo in a more direct way than has previously been available. This technology
may provide the possibility of timely therapeutic intervention in patients
at high risk for suicide.